
automated-news
Metastatic Merkel Cell Carcinoma Pipeline Insight 2025: Immunotherapies, Targeted Agents, and Novel Biologics Reshape the Treatment Landscape | DelveInsight
The therapeutic pipeline for metastatic Merkel cell carcinoma is advancing rapidly, driven by the urgent need for durable treatments in this rare and aggressive neuroendocrine skin cancer. Immune checkpoint inhibitors targeting PD-1/PD-L1 have transformed care, providing lasting responses for some Read Full Article →